J. Heykants

4.3k total citations
64 papers, 3.4k citations indexed

About

J. Heykants is a scholar working on Molecular Biology, Small Animals and Pharmacology. According to data from OpenAlex, J. Heykants has authored 64 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Small Animals and 10 papers in Pharmacology. Recurrent topics in J. Heykants's work include Anesthesia and Sedative Agents (10 papers), Antifungal resistance and susceptibility (9 papers) and Pharmacogenetics and Drug Metabolism (8 papers). J. Heykants is often cited by papers focused on Anesthesia and Sedative Agents (10 papers), Antifungal resistance and susceptibility (9 papers) and Pharmacogenetics and Drug Metabolism (8 papers). J. Heykants collaborates with scholars based in Belgium, United States and Netherlands. J. Heykants's co-authors include Robert Woestenborghs, W. Meuldermans, R. Woestenborghs, G. Cauwenbergh, A. Van Peer, Karel Lavrijsen, P. Van Rooy, W. Lorreyne, Achiel Van Peer and R. De Coster and has published in prestigious journals such as Clinical Infectious Diseases, Chemosphere and Antimicrobial Agents and Chemotherapy.

In The Last Decade

J. Heykants

62 papers receiving 3.2k citations

Peers

Countries citing papers authored by J. Heykants

Since Specialization

Citations

This map shows the geographic impact of J. Heykants's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Heykants with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Heykants more than expected).

Fields of papers citing papers by J. Heykants

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Heykants. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Heykants. The network helps show where J. Heykants may publish in the future.

Co-authorship network of co-authors of J. Heykants

This figure shows the co-authorship network connecting the top 25 collaborators of J. Heykants. A scholar is included among the top collaborators of J. Heykants based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Heykants. J. Heykants is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of the cytochrome P450 enzymes involved in the metabolism of cisapride: in vitro studies of potential co‐medication interactions 2000 ·British Journal of Pharmacology ·Hilde Bohets, Karel Lavrijsen, Jan Hendrickx, Jos Van Houdt, (unknown), Pieter Verboven, W. Meuldermans, J. Heykants	45
2	Population analysis of the non-linear red blood cell partitioning of draflazine following various infusion durations 1997 ·European Journal of Clinical Pharmacology ·Eric Snoeck, (unknown), Philippe Jacqmin, R. Lins, A. Van Peer, Meindert Danhof, Robert Woestenborghs, (unknown), Alain Dupont, J. Heykants	2
3	Linearity of Pharmacokinetics and Model Estimation of Sufentanil 1995 ·Anesthesiology ·E. Gepts, Steven L. Shafer, Frédéric Camu, Donald R. Stanski, Robert Woestenborghs, Achiel Van Peer, J. Heykants	131
4	Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects 1993 ·Clinical Pharmacology & Therapeutics ·(unknown), Achiel Van Peer, Robert Woestenborghs, R. De Coster, J. Heykants, (unknown), Zbigniew Żylicz, (unknown), (unknown)	267
5	Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations 1993 ·Antimicrobial Agents and Chemotherapy ·J.S. Hostetler, J. Heykants, Karl V. Clemons, Robert Woestenborghs, L H Hanson, David A. Stevens	74
6	Determination of risperidone and 9-hydroxyrisperidone in plasma, urine and animal tissues by high-performance liquid chromatography 1992 ·Journal of Chromatography B Biomedical Sciences and Applications ·Robert Woestenborghs, W. Lorreyne, Frank Van Rompaey, J. Heykants	45
7	Comparative metabolism of flunarizine in rats, dogs and man: an in vitro study with subcellular liver fractions and isolated hepatocytes 1992 ·Xenobiotica ·Karel Lavrijsen, Jos Van Houdt, D. Van Dyck, Jan Hendrickx, (unknown), R Hurkmans, W. Meuldermans, L. Le Jeune, W. Lauwers, J. Heykants	28
8	Posttreatment itraconazole levels in the nail 1992 ·Journal of the American Academy of Dermatology ·Marcella Willemsen, Piet De Doncker, (unknown), Robert Woestenborghs, Vera Van de Velde, J. Heykants, J. Van Cutsem, G. Cauwenbergh, Diane Roseeuw	136
9	A predictive model for substrates of cytochrome P450-debrisoquine (2D6) 1992 ·Chemical Research in Toxicology ·Luc Koymans, Nico Vermeulen, S.A.B.E. van Acker, J.M. te Koppele, J. Heykants, Karel Lavrijsen, W. Meuldermans, Gabriëlle M. Donné-Op den Kelder	125
10	Pharmacokinetics of Ritanserin in Patients Undergoing Hemodialysis 1991 ·The Journal of Clinical Pharmacology ·J Zazgórnik, (unknown), F Kokot, Sonja Koch, Achiel Van Peer, Minxue Huang, J. Heykants	3
11	Levels of itraconazole in skin blister fluid after a single oral dose and during repetitive administration 1990 ·Journal of the American Academy of Dermatology ·Monika Schäfer‐Korting, (unknown), (unknown), J. Heykants, H. Behrendt	17
12	Comparative bioavailability of a cisapride suppository and tablet formulation in healthy volunteers 1990 ·European Journal of Clinical Pharmacology ·Thomas Hedner, Jan Hedner, (unknown), Minxue Huang, (unknown), Robert Woestenborghs, A. Van Peer, J. Heykants	14
13	The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects 1989 ·European Journal of Clinical Pharmacology ·A. Van Peer, R. Woestenborghs, J. Heykants, Roberto Gasparini, (unknown)	140
14	PHARMACOKINETICS OF DROPERIDOL IN SURGICAL PATIENTS UNDER DIFFERENT CONDITIONS OF ANAESTHESIA 1988 ·British Journal of Anaesthesia ·K. A. Lehmann, A. Van Peer, (unknown), Roberto Gasparini, J. Heykants	19
15	In Vitro Screening for Hepatotoxicity of Xenobiotics using Isolated Hepatocytes 1988 ·Alternatives to Laboratory Animals ·Karel Lavrijsen, (unknown), Jos Van Houdt, (unknown), W. Meuldermans, J. Heykants	2
16	Hypnoanalgesia with R 8110/fentanyl in the dog: pharmacodynamic and pharmacokinetic interactions 1988 ·Journal of Veterinary Pharmacology and Therapeutics ·Johan Monbaliu, A.‐D. Degryse, L. Ooms, P. van Dijk, E. Lagerweij, M. Michiels, R. Woestenborghs, J. Heykants	2
17	Going to extremes 1987 ·BYTE archive ·(unknown), H Noorduin, (unknown), J. Heykants	0
18	International Drug Registration Efforts 1987 ·The Journal of Clinical Pharmacology ·V. Schuermans, (unknown), (unknown), J. Heykants, A. Reyntjens, (unknown), (unknown)	2
19	Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs. 1984 ·Drug Metabolism and Disposition ·W. Meuldermans, Jan Hendrickx, W. Lauwers, (unknown), R Hurkmans, (unknown), Robert Woestenborghs, J. Heykants	12
20	Intramuscular haloperidol decanoate for neuroleptic maintenance therapy Efficacy, dosage schedule and plasma levels AN OPEN MULTICENTER STUDY 1980 ·Acta Psychiatrica Scandinavica ·(unknown), (unknown), (unknown), J. Heykants, R. Woestenborghs, (unknown), A. Reyntjens, I. van Wijngaarden	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact